NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
AVM Biotechnology Inc
Therapeutic Advances in Childhood Leukemia Consortium
Barbara Ann Karmanos Cancer Institute